| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |